JP2003531196A - 超短時間作用型催眠性バルビツール酸塩 - Google Patents

超短時間作用型催眠性バルビツール酸塩

Info

Publication number
JP2003531196A
JP2003531196A JP2001578413A JP2001578413A JP2003531196A JP 2003531196 A JP2003531196 A JP 2003531196A JP 2001578413 A JP2001578413 A JP 2001578413A JP 2001578413 A JP2001578413 A JP 2001578413A JP 2003531196 A JP2003531196 A JP 2003531196A
Authority
JP
Japan
Prior art keywords
branched
hydrogen
unbranched
saturated
unsaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001578413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003531196A5 (enExample
Inventor
パスカル ドラズギャラ
ピーター ジー． ミリネル
Original Assignee
アリックス セラピューティクス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アリックス セラピューティクス filed Critical アリックス セラピューティクス
Publication of JP2003531196A publication Critical patent/JP2003531196A/ja
Publication of JP2003531196A5 publication Critical patent/JP2003531196A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001578413A 2000-04-24 2001-04-24 超短時間作用型催眠性バルビツール酸塩 Pending JP2003531196A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19914400P 2000-04-24 2000-04-24
US60/199,144 2000-04-24
PCT/US2001/013246 WO2001081319A2 (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates

Publications (2)

Publication Number Publication Date
JP2003531196A true JP2003531196A (ja) 2003-10-21
JP2003531196A5 JP2003531196A5 (enExample) 2008-06-19

Family

ID=22736404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001578413A Pending JP2003531196A (ja) 2000-04-24 2001-04-24 超短時間作用型催眠性バルビツール酸塩

Country Status (6)

Country Link
US (4) US6387914B2 (enExample)
EP (1) EP1276728A2 (enExample)
JP (1) JP2003531196A (enExample)
AU (2) AU5723001A (enExample)
CA (1) CA2404898A1 (enExample)
WO (1) WO2001081319A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276728A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics Ultrashort acting hypnotic barbiturates
US7049326B2 (en) * 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US6750238B1 (en) * 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US10537061B2 (en) * 2010-02-26 2020-01-21 Cnh Industrial America Llc System and method for controlling harvest operations
WO2014014960A1 (en) * 2012-07-16 2014-01-23 Dignity Health Treating of epilepsy and alcohol addiction with creatine
CA2961410C (en) 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
EP3247359A4 (en) 2015-01-25 2018-08-08 India Globalization Capital, Inc. Composition and method for treating seizure disorders
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
EP3471746A4 (en) 2016-06-15 2020-02-26 India Globalization Capital, Inc. METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06214344A (ja) * 1992-10-22 1994-08-05 Konica Corp ハロゲン化銀写真感光材料
JPH07120865A (ja) * 1993-10-21 1995-05-12 Konica Corp ハロゲン化銀写真感光材料

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CS176667B1 (enExample) * 1975-02-17 1977-06-30
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them
DE69032871T2 (de) * 1989-11-14 1999-09-09 Sloan-Kettering Institute For Cancer Research Neue potente induktoren terminaler differenzierung und verfahren zu ihrer verwendung
CH678394A5 (enExample) * 1990-08-22 1991-09-13 Cerny Erich H
US5414085A (en) * 1992-04-06 1995-05-09 Biosite Diagnostics, Inc. Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
US6335332B1 (en) * 1997-06-21 2002-01-01 Roche Diagnostics Gmbh Barbituric acid derivatives with antimetastatic and antitumor activity
EP1276728A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics Ultrashort acting hypnotic barbiturates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06214344A (ja) * 1992-10-22 1994-08-05 Konica Corp ハロゲン化銀写真感光材料
JPH07120865A (ja) * 1993-10-21 1995-05-12 Konica Corp ハロゲン化銀写真感光材料

Also Published As

Publication number Publication date
USRE41289E1 (en) 2010-04-27
WO2001081319A2 (en) 2001-11-01
AU5723001A (en) 2001-11-07
US20030100575A1 (en) 2003-05-29
US6387914B2 (en) 2002-05-14
US7041673B2 (en) 2006-05-09
US6683086B2 (en) 2004-01-27
AU2001257230B2 (en) 2006-09-14
WO2001081319A3 (en) 2002-05-16
CA2404898A1 (en) 2001-11-01
US20040167143A1 (en) 2004-08-26
EP1276728A2 (en) 2003-01-22
US20020013330A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
USRE41289E1 (en) Ultrashort acting hypnotic barbiturates
CA2024156C (fr) Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3
EP0172096B1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
JP2955318B2 (ja) 置換ピリミジン誘導体
KR920006781B1 (ko) 디하이드로 피리다진온 유도체를 제조하는 방법
CA2150162C (fr) Nouveau n-pyridyl carboxamides et derives, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
TWI385158B (zh) １ｈ-喹唑啉-２，４-二酮
JPH05331148A (ja) カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物
US4503073A (en) 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
AU2001257230A1 (en) Ultrashort acting hypnotic barbiturates
US4372957A (en) Treatment with dialkoxy pyridopyrimidines
US4835154A (en) 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
JPS61500019A (ja) キナゾリン及びイソキノリン誘導体
JP2544183B2 (ja) 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
IL99134A (en) Transformed histories of pyrimidine, method of preparation and use as reactants
EP0134928A1 (en) Imidazo[1,5-a]pyrimidine derivatives and process for their preparation
FR2687677A1 (fr) Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
CS209856B2 (en) Method of making the new derivatives of the aminoacids
JP2003511376A (ja) 新規なピリミジン−２，４，６−トリオン誘導体、その製造方法及びそれらを含む医薬製剤
CA2405025A1 (en) (2-aminoethyl) oxime derivatives for the treatment of depression
EP0502110B1 (fr) Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique
CA1205804A (fr) Procede de preparation de nouvelles imidazoquinoxalines et de leurs sels
CA2359107A1 (en) New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
IE63246B1 (en) Novel 4-chloro-3-sulfamoylbenzoic acid hydrazides a process for the preparation thereof,pharmaceutical compositions containing them and their use as medicaments
FR2593181A1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080423

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110425

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111005